Stryker (SYK) Long-Term Investments (2009 - 2010)
Stryker (SYK) posted quarterly Long-Term Investments of -$110.0 million for Q4 2010, down 170.06% year-over-year from $157.0 million in Q4 2009, and down 170.06% on a QoQ basis from $157.0 million in Q4 2009.
Stryker (SYK) Long-Term Investments (2009 - 2010) Analysis & Trends
Stryker has reported Long-Term Investments for 2 years, with the latest figure at -$110.0 million in Q4 2010.
- Long-Term Investments for Q4 2010 came in at -$110.0 million, down 170.06% year-over-year; the trailing twelve-month figure through Dec 2010 was -$110.0 million (down 170.06% YoY), and the FY2010 annual result was -$110.0 million, down 170.06% from the prior year.
- Long-Term Investments slipped to -$110.0 million in Q4 2010, from $157.0 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $157.0 million in Q4 2009 and troughed at -$110.0 million in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -110.00 Mn |
| Dec 31, 2009 | 157.00 Mn |